Evidence map›Paper›PMID 29141691›Full record

ArticleJournal of experimental & clinical cancer research : CR2017

Involvement of aberrantly activated HOTAIR/EZH2/miR-193a feedback loop in progression of prostate cancer.

Zhixin Ling, Xiaoyan Wang, Tao Tao, Lei Zhang, Han Guan, Zonghao You, Kai Lu, Guangyuan Zhang, Shuqiu Chen, Jianping Wu and 4 more

Open access · goldAbstract read
In one paragraph

Article in Journal of experimental & clinical cancer research : CR, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 1 pooled it
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 1 synthesis or guideline pooled it, 50 citations in OpenAlex.

  1. Pooled it
  2. International journal of biological sciences · 2026
    Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Roles of noncoding RNAs in preeclampsia.Reproductive biology and endocrinology : RB&E · 2021
    Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 1 country.

Zhixin LingDepartment of Urology, Affiliated Zhongda Hospital of Southeast University, Nanjing, Jiangsu, 210009, China.
Xiaoyan WangDepartment of Nursing, Affiliated Zhongda Hospital of Southeast University, Nanjing, Jiangsu, 210009, China.
Tao TaoDepartment of Urology, Anhui Provincial Hospital, Anhui Medical University, Hefei, 230001, China.
Lei ZhangDepartment of Urology, Affiliated Zhongda Hospital of Southeast University, Nanjing, Jiangsu, 210009, China.
Han GuanDepartment of Urology, the First Affiliated Hospital of Bengbu Medical College, Bengbu, 233004, China.
Zonghao YouDepartment of Urology, Affiliated Zhongda Hospital of Southeast University, Nanjing, Jiangsu, 210009, China.
Kai LuDepartment of Urology, Affiliated Zhongda Hospital of Southeast University, Nanjing, Jiangsu, 210009, China.
Guangyuan ZhangDepartment of Urology, Affiliated Zhongda Hospital of Southeast University, Nanjing, Jiangsu, 210009, China.
Shuqiu ChenDepartment of Urology, Affiliated Zhongda Hospital of Southeast University, Nanjing, Jiangsu, 210009, China.
Jianping WuDepartment of Urology, Affiliated Zhongda Hospital of Southeast University, Nanjing, Jiangsu, 210009, China.
Jinke QianDepartment of Urology, Binhai People's Hospital, Yancheng, Jiangsu, 224500, China.
Hui LiuDepartment of Urology, Binhai People's Hospital, Yancheng, Jiangsu, 224500, China.
Bin XuDepartment of Urology, Affiliated Zhongda Hospital of Southeast University, Nanjing, Jiangsu, 210009, China. njxb1982@126.com.
Ming ChenDepartment of Urology, Affiliated Zhongda Hospital of Southeast University, Nanjing, Jiangsu, 210009, China. mingchenseu@126.com.
Southeast University · CNZhongda Hospital Southeast University · CNBinzhou People's Hospital · CNAnhui Medical University · CNBengbu Medical College · CN

Funding

Fundamental Research Funds for the Central Universities and the Scientific Research Innovation Program for College and University Graduates of Jiangsu Province KYZZ16_0135Jiangsu Provincial Medical Talent ZDRCA2016080Jiangsu Provincial Medical Youth Talent QNRC2016821 and QRNC2016820National Natural Science Foundation of China 81672551, 81572517, 81370849 and 81300472Natural Science Foundation of Jiangsu Province BK20161434, BL2013032, BK20150642 and BK2012336Six talent peaks project in Jiangsu Province, Jiangsu Provincial Medical Innovation Team CXTDA2017025
6 · The paper itself

Abstract

backgroundThough androgen deprivation therapy is the standard treatment for prostate cancer (PCa), most patients would inevitably progress to castration-resistant prostate cancer (CRPC) which is the main cause of PCa death. Therefore, the identification of novel molecular mechanism regulating cancer progression and achievement of new insight into target therapy would be necessary for improving the benefits of PCa patients. This study aims to study the function and regulatory mechanism of HOTAIR/EZH2/miR-193a feedback loop in PCa progression.

methodsMSKCC and TCGA datasets were used to identify miR-193a expression profile in PCa. Cell Counting Kit-8 (CCK-8) assays, colony formation, invasion, migration, flow cytometry, a xenograft model and Gene Set Enrichment Analysis were used to detect and analyze the biological function of miR-193a. Then, we assessed the role of HOTAIR and EZH2 in regulation of miR-193a expression by using plasmid, lentivirus and small interfering RNA (siRNA). Luciferase reporter assays and chromatin immunoprecipitation assays were performed to detect the transcriptional activation of miR-193a by EZH2 and HOTAIR. Further, qRT-PCR and luciferase reporter assays were conducted to examine the regulatory role of miR-193a controlling the HOTAIR expression in PCa. Finally, the correlation between HOTAIR, EZH2 and miR-193a expression were analyzed using In situ hybridization and immunohistochemistry.

resultsWe found that miR-193a was significantly downregulated in metastatic PCa through mining MSKCC and TCGA datasets. In vitro studies revealed that miR-193a inhibited PCa cell growth, suppressed migration and invasion, and promoted apoptosis; in vivo results demonstrated that overexpression of miR-193a mediated by lentivirus dramatically reduced PCa xenograft tumor growth. Importantly, we found EZH2 coupled with HOTAIR to repress miR-193a expression through trimethylation of H3K27 at miR-193a promoter in PC3 and DU145 cells. Interestingly, further evidence illustrated that miR-193a directly targets HOTAIR showing as significantly reduced HOTAIR level in miR-193a overexpressed cells and tissues. The expression level of miR-193a was inversely associated with that of HOTAIR and EZH2 in PCa.

conclusionThis study firstly demonstrated that miR-193a acted as tumor suppressor in CRPC and the autoregulatory feedback loop of HOTAIR/EZH2/miR-193a served an important mechanism in PCa development. Targeting this aberrantly activated feedback loop may provide a potential therapeutic strategy.

Indexed as

Down-RegulationAnimalsCell Line, TumorCell MovementCell ProliferationDisease ProgressionEnhancer of Zeste Homolog 2 ProteinEpigenesis, GeneticFeedback, PhysiologicalGene Expression Regulation, NeoplasticHumansMaleMiceMicroRNAsNeoplasm InvasivenessPromoter Regions, GeneticEnhancer of Zeste Homolog 2 ProteinEZH2 protein, humanHOTAIR long untranslated RNA, humanMicroRNAsMIRN193 microRNA, humanRNA, Long NoncodingEZH2HOTAIRMiR-193aProgressionProstate cancer

Identifiers

PMID29141691
PMCPMC5688662
OpenAlexW2768133407

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.